In our cohort, hospitalized CF carriers develop indeed a form of COVID-19 more likely characterized by acute respiratory distress syndrome (PaO2/FiO2 ratio ≤ 250 mmHg), high inflammatory response (CRP ≥ 20 mg/dL), and, for some of them hyperlipasemia. This evidence concerns the gene CRP and cystic fibrosis.